Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending September 30, 2022 was -17.61% (a -3189.47% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -275.22%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 19.08% (a -62.12% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 50.37% (a -67.03% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 152.76% (a 178.96% increase from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending September 30, 2022 was -0.16% (a -101.27% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -100.84% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -0.16% | 12.64% | 18.91% | 19.08% |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of Atreca, Inc.
Most recent Selling, General and Administrative (SG&A) Expenses Growthof BCEL including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Atreca, Inc.
Atreca, Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -17.61% | 0.57% | 10.04% | – |
| 2021 | 10.05% | 32.99% | 24.36% | 9.8% | 19.08% |
| 2020 | -4.14% | 35.98% | 82.58% | 182.88% | 50.37% |
| 2019 | 269.39% | 198.04% | -45.23% | -64.65% | 152.76% |
| 2018 | – | – | -72.93% | -66.45% | 54.76% |
| 2017 | – | – | – | – | -35.38% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology